Sun Pharma Laboratories Limited, a subsidiary of Sun Pharmaceutical Industries Ltd, has received an order from the statutory authority under the Goods and Services Tax Act, 2017 for the financial year 2018-19, imposing interest of Rs. 89,99,104 and penalty of Rs. 10,90,800. The company is taking appropriate actions, including filing an appeal against the order. There is no material impact on the financial, operational, or other activities of the company.